Inventor · disambiguated record
Stig Hansen
Also filed as: HANSEN STIG · HANSEN STIG K
7 granted patents·16 pending applications·38 citations·filing 2003–2024
80Inventor score
Files withCARMOT THERAPEUTICS INC8SUNESIS PHARMACEUTICALS INC5ERLANSON DANIEL A2HANSEN STIG2VIRACTA THERAPEUTICS INC2
Top patents by PatentIndex Score
23 records- 0189US8778977B2Pyridinonyl PDK1 inhibitorsLIND KENNETH EGNARD·Filed 2007·Granted Jul 15, 2014·21 cites·15 claims
- 0279US6784205B2Compounds that modulate the activity of PTP-1B and TC-PTPSUNESIS PHARMACEUTICALS INC·Filed 2003·Granted Aug 31, 2004·12 cites·24 claims
- 0379US2025092025A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0473US2024207258A1Heterocyclic pdk1 inhibitors for use to treat cancerVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0570US2023089073A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0670US2024252492A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0768US2023099829A1Heterocyclic pdk1 inhibitors for use to treat cancerVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0866US12281149B2Modulators of G-protein coupled receptorsCARMOT THERAPEUTICS INC·Filed 2022·Granted Apr 22, 2025·0 cites·11 claims
- 0966US2024383960A1Modulators of G-Protein Coupled ReceptorsCARMOT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1065US7214487B2Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidatesSUNESIS PHARMACEUTICALS INC·Filed 2003·Granted May 8, 2007·5 cites·19 claims
- 1162US9873693B2Methods of treatment using pyridinonyl PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted Jan 23, 2018·0 cites·15 claims
- 1260US10107798B2Methods of chemotype evolutionHANSEN STIG·Filed 2009·Granted Oct 23, 2018·0 cites·57 claims
- 1360US2018370966A1Methods of treatment using pyridinonyl pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1459US2008293777A1Weight Loss TreatmentERLANSON DANIEL A·Filed 2008·Application pending·0 cites
- 1559US2023357347A1Modulators of g-protein coupled receptorsCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1657US2024425513A1Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28CARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1752US2018238863A1Chemical synthesisHANSEN STIG·Filed 2018·Application pending·0 cites
- 1852US2008220536A1Methods for Identifying Compounds that Modulate Enzymatic Activities by Employing Covalently Bonded Target-Extender Complexes with Ligand CandidatesERIANSON DANIEL A·Filed 2007·Application pending·0 cites
- 1950US2004147596A1Compounds that modulate the activity of PTP-1B and TC-PTPFiled 2004·Application pending·0 cites
- 2048US2019015410A1Heterocyclic pdk1 inhibitors for use to treat cancerSUNESIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2146US11535660B1Modulators of G-protein coupled receptorsCARMOT THERAPEUTICS INC·Filed 2019·Granted Dec 27, 2022·0 cites·34 claims
- 2235US2004014140A1Methods for identifying allosteric sitesFiled 2003·Application pending·0 cites
- 2335US2011301235A1Organoselenium compounds and uses thereofERLANSON DANIEL A·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stig Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →